Physician profile
Michael C Hanus
NPI 1639172588
$3,136.38
in general payments reported to CMS, 2019-2025
16 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $36.65 · 2021: $222 · 2022: $353 · 2023: $286 · 2024: $325 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $1,482.10 | 2019-2025 | Optune, Optune Gio |
| Boston Scientific Corporation | $272.40 | 2019-2024 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $250.87 | 2022-2024 | Prolaris |
| Janssen Biotech, INC. | $235.86 | 2019-2024 | Erleada |
| Reflexion Medical, INC. | $189.83 | 2022-2023 | Reflexion Medical Radiotherapy System |
| Mevion_medical_systems_inc | $132.49 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $121.85 | 2025 | Imfinzi |
| Blue Earth Diagnostics | $103.72 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $90.14 | 2019-2025 | Libtayo |
| Pfizer INC. | $80.14 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $62.82 | 2024-2025 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $42.11 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $23.18 | 2023 | |
| Teleflex LLC | $19.71 | 2025 | Barrigel |
| Fortovia Therapeutics, INC. | $16.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $12.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hanus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.